Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2005
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680243A Process for the preparation of non-steroidal glucocorticoid receptor modulators
10/12/2005CN1680238A Preparation and use of compounds i.e., 1, 3-dihydroxy-5-alkyl benzene as inhbitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1680235A Preparation and use of compounds i.e., falcarindiol as inhibitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1679956A Treatment of androgen-deprivation induced osteoporosis
10/12/2005CN1679953A Pharmaceutical composition for regulating lipid concentration
10/12/2005CN1679939A Medicinal composition for contraception and its usage
10/12/2005CN1679690A Granular formulation for treating hyperthyroidism and preparation thereof
10/12/2005CN1679683A Capsule for treating hyperthyroidism and preparation thereof
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222292C Fulvestrant formulation
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953785 Estra-1,3,5(10)-triene derivatives
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/06/2005WO2005092349A1 Insulin resistance improving agent
10/06/2005WO2005092346A1 Using combination of estrogen and progestin with ultra low dose for long term oral contraception
10/06/2005WO2005092309A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222174 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222114 Use of new etonogestrel esters
10/06/2005US20050222113 New etonogestrel esters
10/06/2005US20050222104 e.g. 3 beta -Formyloxy-21-acetyloxy-5-pregnen-20-one; modulate immunology response; disease associated to an excess of glucocorticoids; Cushing's syndrome, iatrogenic hypercortisolism or depression
10/06/2005US20050222100 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
10/06/2005US20050222099 Pregnane steroids for use in the treatment of cns disorders
10/06/2005US20050221483 Propagating pluripotent stem cells from monocytes; tissue engineering; cell therapy; treating cardiovascular, arteriosclerotic, metabolic and liver disorders; cell expressing albumin protein; cirrhosis of the liver
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050220900 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
10/06/2005US20050220855 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease
10/06/2005US20050220722 Method of decreasing fasting sugars and weight gains in diabetic patients
10/06/2005CA2560927A1 Insulin resistance-improving agent
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1581307A2 Irs modulators
10/05/2005EP1368007B1 Coating and binding agent for pharmaceutical formulations with improved storage stability
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1676132A Thio-oxy pyrimidine formulation and its preparing method
10/05/2005CN1221550C Crgstalline form II of cabergoline
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951874 Compounds
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951850 Dipeptide derivatives
09/2005
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005US20050215616 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol; treating vaginal and skin atrophy
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215528 Gnrh agonist combination drugs
09/29/2005US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus
09/29/2005US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock
09/29/2005US20050214291 Treatment method
09/29/2005CA2563345A1 Follicle stimulating hormone superagonists
09/28/2005EP1580192A2 16-Hydroxyestratrienes as selective estrogens
09/28/2005EP1579865A1 Means for preventing and curing endocrine system disturbances
09/28/2005EP1579856A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
09/28/2005EP1579855A1 Novel dry powder inhalation system for transpulmonary administration
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578727A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators
09/28/2005EP1578726A2 Tetrahydroquinoline derivatives
09/28/2005EP1578440A1 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674931A T cell receptor CDR3 sequences and methods for detection
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1672685A New contraception medicine
09/28/2005CN1220696C 16 alpha-methyl or ethyl substituted estrogens
09/28/2005CN1220491C Non-oral androgenic steroids used in preparation of medicine for improvement of raising sex hormones combined globulin level
09/28/2005CN1220484C Microparticles for pulmonary administation
09/27/2005US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
09/27/2005US6949555 Use of organic compounds
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949531 14 β, 16, 17-methylene steroids as novel androgens
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 290